Mechanisms of action of glucagon-like peptide 1 in the pancreas
Top Cited Papers
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 113 (3) , 546-593
- https://doi.org/10.1016/j.pharmthera.2006.11.007
Abstract
No abstract availableKeywords
This publication has 441 references indexed in Scilit:
- Exenatide inhibits β-cell apoptosis by decreasing thioredoxin-interacting proteinBiochemical and Biophysical Research Communications, 2006
- The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits β-cell apoptosis in vitroBiochemical and Biophysical Research Communications, 2005
- Expression of cAMP-Regulated Guanine Nucleotide Exchange Factors in Pancreatic β-CellsBiochemical and Biophysical Research Communications, 2000
- Expression of Adenylyl Cyclase Subtypes in Pancreatic β-CellsBiochemical and Biophysical Research Communications, 1999
- Protein Kinase B Is Expressed in Pancreatic β Cells and Activated upon Stimulation with Insulin-like Growth Factor IBiochemical and Biophysical Research Communications, 1998
- Point Mutations in the First and Third Intracellular Loops of the Glucagon-like Peptide-1 Receptor Alter Intracellular SignalingBiochemical and Biophysical Research Communications, 1996
- Cyclic AMP Phosphodiesterases of Human and Rat Islets of Langerhans: Contributions of Types III and IV to the Modulation of Insulin SecretionBiochemical and Biophysical Research Communications, 1995
- Insulin-promoter-factor 1 is required for pancreas development in miceNature, 1994
- Cloning and Functional Expression of a Human Glucagon-like Peptide-1 ReceptorBiochemical and Biophysical Research Communications, 1993
- Glucagonlike peptide-1 (7–36)amide suppresses glucagon secretion and decreases cyclic AMP concentration in cultured in-R1-G9 cellsBiochemical and Biophysical Research Communications, 1992